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ABSTRACT: We have investigated at the oligomeric level interactions between
Aβ(25−35) and Tau(273−284), two important fragments of the amyloid-β and
Tau proteins, implicated in Alzheimer’s disease. We are able to directly observe the
coaggregation of these two peptides by probing the conformations of early
heteroligomers and the macroscopic morphologies of the aggregates. Ion-mobility
experiment and theoretical modeling indicate that the interactions of the two
fragments affect the self-assembly processes of both peptides. Tau(273−284) shows
a high affinity to form heteroligomers with existing Aβ(25−35) monomer and
oligomers in solution. The configurations and characteristics of the heteroligomers
are determined by whether the population of Aβ(25−35) or Tau(273−284) is
dominant. As a result, two types of aggregates are observed in the mixture with
distinct morphologies and dimensions from those of pure Aβ(25−35) fibrils. The
incorporation of some Tau into β-rich Aβ(25−35) oligomers reduces the
aggregation propensity of Aβ(25−35) but does not fully abolish fibril formation. On the other hand, by forming complexes
with Aβ(25−35), Tau monomers and dimers can advance to larger oligomers and form granular aggregates. These
heteroligomers may contribute to toxicity through loss of normal function of Tau or inherent toxicity of the aggregates
themselves.
■ INTRODUCTION
Senile plaques of amyloid-β (Aβ) and neurofibrillary tangles
(NFT) of Tau are pathophysiological markers of Alzheimer’s
disease (AD). Tau proteins include six different intracellular,
intrinsically disordered isoforms consisting of two functional
domains. The projection domain mediates interactions of
microtubules with neural plasma membrane and cytoskeletal
elements and is involved in signal transduction, while the Tau
microtubule binding pseudorepeat domain (MTBR) regulates
microtubule assembly from tubulin (for a comprehensive
review, see ref 1). Aggregation of Tau into NFT is promoted in
cases of hyperphosphorylation or deficiency in dephosphor-
ylation.1−3 More than 37 mutations of Tau isoforms have been
shown to induce neurodegenerative diseases (e.g., frontotem-
poral dementia);3,4 however, there are no Tau mutations
directly linked to any known familial form AD. While a “loss of
function” hypothesis is often invoked to explain the role of Tau
aggregation in AD, the latter does not fully account for the
etiology of the disease, and does not address the role of Aβ in
AD, or its possible interaction with Tau.5
Unlike Tau which resides in the neurons, the Aβ peptide is
produced in the extracellular space from the proteolytic
cleavage of a large transmembrane amyloid β-protein precursor
protein (APP). An amyloid cascade hypothesis has been
proposed that stipulates that AD is caused by the aggregation of
Aβ,5 with β-rich toxic oligomers6,7 or fibrillar aggregates8
signaling cell apoptosis or decreasing synaptic plasticity.
However, this hypothesis has been challenged given the lack
of strong correlation between the amount of Aβ produced, or
senile plaques deposited, and neuronal loss or cognitive
impairment.9,10 The observation that Aβ monomers or soluble
oligomers permeate cell membranes11,12 and form highly
functional multimeric aggregates6 capable of interfering with
normal cellular activities is offering a new research direction in
AD. Yet another hypothesis, and the one that we will focus on
in this work, is that the interaction of Aβ and Tau may be
significant in AD. Indeed, while the Aβ peptide is produced in
the extracellular space, soluble Aβ oligomers have been shown
to exist in the intracellular space as well13 and interact with a
variety of proteins14 including Tau.15−21 Exposure of Tau to Aβ
oligomers22 could lead to loss of microtubule integrity,15
formation of new, insoluble aggregates,23 or an enhancement of
NFT formation.8 Tau has been shown to induce Aβ toxicity in
hippocampal neurons,24 while Aβ-mediated Tau phosphor-
ylation has been discovered in both hippocampal and
cholinergic neurons.19,25−27
The full length Aβ is a 39−43-residue peptide with Aβ(1−
40) and Aβ(1−42) being the two most abundant isoforms. The
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full length Tau, depending on its isoforms, can be as long as
400 residues, and studying complexes of Aβ and Tau poses a
real challenge, both from an experimental and computational
standpoint. We then turn in this work to the study of a model
system that captures the essential features of Aβ and Tau
assembly. We use a combination of ion-mobility mass
spectrometry (IM-MS), atomic force microscopy (AFM), and
computational modeling to investigate the interactions between
an Aβ and a Tau fragment: Aβ(25−35) and Tau(273−284).
These two peptide fragments contain important regions of the
full Aβ and Tau proteins, and we and others have studied early
oligomer conformations and aggregation propensities of both
peptides.28−33 Aβ(25−35) is an amphipathic peptide with
similar aggregation propensity and toxicity to the full length
Aβ(1−42).34,35 Takashima et al.27 have shown that embryonic
rat hippocampal neurons undergo progressive degeneration and
that Tau phosphorylation is enhanced after exposure to
Aβ(25−35), similar to the result obtained with Aβ(1−40) by
Busciglio and co-workers.25 Tau(273−284) is in the second
repeat (R2) of MTBR and encompasses the PHF6*
hexapeptide (VQIINK), one of the two hexapeptides known
to play an important role in Tau aggregation.36−39 It has also
been shown experimentally that Tau binds between the middle
and C-terminal regions of Aβ(1−42) (the region of APP
inserted into the cell membrane).23 A recent theoretical work
by Nussinov and co-workers also suggests that Aβ oligomers
interact more strongly with R2 of MTBR than R3 or R4.40
Although R2 appears in some but not all Tau isoforms
(encoded only by exon 10 of the MAPT protein), changing the
ratio of four-repeat Tau to three-repeat Tau is sufficient to
cause serious degeneration in microtubule assembly.41
Of note is that both peptides contain a hydrophobic stretch
of six-residue sequence, i.e., PHF6* in Tau(273−284) and
GAIIGL from Aβ(25−35). These two hexapeptides have been
shown to adopt steric zipper motifs that facilitate amyloid fibril
formation.36,42,43 The sequences of the fragments are shown in
Figure 1.
■ MATERIALS AND METHODS
All peptides have blocked termini to minimize the effect of
terminal charges. Lyophilized samples of Ac-Tau(273−284)-
NH2 were purchased from Genscript (Piscataway, NJ, USA).
Ac-Aβ(25−35)-NH2 was synthesized by FMOC (N-(9-
fluorenyl)methoxycarbonyl) chemistry. The peptide was
purified by reverse-phase high-performance liquid chromatog-
raphy (HPLC) and characterized by mass spectrometry and
amino acid analysis to confirm the purity and integrity of the
peptide (>95% purity). Working stock solutions (2 mM for the
Ac-Tau(273−284)-NH2 and 500 μM for Ac-Aβ(25−35)-NH2)
were prepared by dissolving the lyophilized peptide in filtered
deionized water. This stock was divided into several tubes,
flash-frozen in liquid nitrogen, and stored at −80 °C until use.
The concentration of peptide samples in IM-MS and AFM
experiments is 200 μM. Polydisperse heparin of 11 kDa was
from Sigma-Aldrich (St. Louis, MO, USA) and stocked at 1
mM concentration in water at room temperature.
Ion-Mobility Mass Spectrometry. In IM-MS experi-
ments, stock solutions were diluted in water to a desired
concentration, loaded into gold coated nano-electrospray
ionization (ESI) capillaries, and electrosprayed on a home-
built instrument.44 Ions were pulled through a 200 cm long,
helium filled drift cell under the influence of a weak electrical
field and the drag force created from collisions with buffer gas
ions. Particular species with specific m/z can be mass-selected,
and their arrival time distributions can be measured at different
pressure to drift voltage ratios (P/V), allowing the determi-
nation of reduced mobility K0 and experimental collision cross-
sections σ.45
Atomic Force Microscopy. AFM images were collected
using an Asylum MFP-3D-SA system (Asylum Research, Santa
Barbara, CA, USA). Details about AFM protocol have been
described previously.46 All images were collected at 1 Hz using
512 × 512 scan points. Images were processed using Igor Pro
software and were modified by masking fibrils and then
applying a first-order flatten to height images (“Magic Mask” in
MFP3D software). All height and length measurements of
single fibrils and granular aggregates were conducted using Igor
Pro, and each reported value is the average of 20 measure-
ments.
Molecular Dynamics Simulations. Temperature-based
replica exchange molecular dynamics (T-REMD) simulations
were performed using the GROMACS 4.6.3 package47,48 with a
combination of the OPLS-AA force field49−52 and TIP3P
water.53 In these simulations, the initial conformation of Ac-
Aβ(25−35)-NH2 is a β-hairpin obtained from T-REMD
simulations of the same peptide using the same force field
(data not shown), and also consistent with a previous
simulation of free terminal Aβ(25−35) by Larini and Shea.31
An initial Ac-Tau(273−284)-NH2 was chosen from the T-
REMD simulations described in ref 30. Structures obtained
from these simulations were minimized in the gas phase to
mimic the dehydration process that occurred when solution-
phase structures enter a solvent-free environment. Their
collision cross-sections were computed using the trajectory
method available from the Mobcal package.54,55
■ RESULTS AND DISCUSSION
Tau(273−284) Binds to Aβ(25−35) with High Affinity
To Form Heteroligomers. All IM-MS experiments are
performed on a home-built IM-MS instrument described
previously.44 The mass spectra of Ac-Aβ(25−35)-NH2, Ac-
Tau(273−284)-NH2, and a mixture of both at 1:1 ratio are
shown in Figure 2. Water is used in place of buffer to slow
down aggregation kinetics, as well as minimize the charge
screening effect of buffer ions that may affect aggregation.
The mass spectrum of Ac-Aβ(25−35)-NH2 (Figure 2A)
contains two major peaks at 550 m/z (n/z 1/2) and 1101 m/z
(n/z 1/1), where n is the Aβ(25−35) oligomer size and z is the
Figure 1. (A) Full length four-repeat Tau and location of PHF6* and
the Tau(273−284) construct used in this study (see Larini et al.30
Adapted in part from ref 30. Copyright 2013 Royal Society of
Chemistry.). The longest Tau isoforms contain either three or four
imperfect repeats in the microtubule-binding pseudorepeat domain
(MTBR). (B) Full length Aβ(1−42) with different regions and the
peptide sequence of Aβ(25−35). All peptides studied here have
acetylated N-termini and amidated C-termini. The hydrophobic
hexapeptide fragments are color coded in red.
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charge. Less intense peaks are observed at 734 m/z (n/z 2/3),
826 m/z (n/z 3/4), and 1407 m/z (n/z 9/7). The arrival time
distributions (ATDs) at m/z other than 1101 contain either a
single oligomer species or a single family of conformations (see
Supporting Information Figure S1A−C,E). ATDs of the n/z 1/
1 peak contain multiple features from dimer to hexamer
(Supporting Information Figure S1D). The progression of
oligomer cross-sections σ as a function of oligomer size n (see
Figure 3A) shows a positive deviation from the isotropic
oligomer model starting at the trimer stage,56 indicating the
formation of extended oligomers. Based on our earlier studies
on free terminal Aβ(25−35),31,32 we can ascribe these extended
oligomers to β-rich oligomers. Formation of β-rich oligomers is
consistent with the fibril formation propensity of the peptide
probed by AFM (see the next section).
The mass spectrum of Ac-Tau(273−284)-NH2 (Figure 2B)
consists of two peaks at 470 m/z (k/z 1/3) and 705 m/z (k/z
1/2) where k is the oligomer number of Ac-Tau(273−284)-
NH2. Peaks at higher m/z are not observed, consistent with the
fact that peptide oligomerization occurs at a much slower rate
compared to the same peptide in buffer solution.30 The dimer is
the largest oligomer observed (the ATD of the peak at 705 m/z
is shown in the inset of Figure 2B). In the absence of
aggregation-promoting factors (e.g., heparin), this peptide is
unable to form any structural aggregates.30,39 Furthermore,
previous simulations and experimental cross-sections (σexp =
310−313 Å2 for z = +2 and +3) suggest that the Tau monomer
is in a relatively compact conformation (i.e., β-turn or β-
hairpin). Simulations suggest that aggregation is controlled by a
conformational transition of the monomers which later
associate to form extended dimers.30
The mass spectrum of the mixture (Figure 2C) shows strong
peaks for Ac-Tau(273−284)-NH2 monomer, but the peaks
associated with Ac-Aβ(25−35)-NH2 are strongly suppressed,
replaced by several new peaks composed of peptides from both
fragments. These mass spectral peaks are annotated with [n +
k]/z where n is the oligomer number of Ac-Aβ(25−35)-NH2, k
is the oligomer number of Ac-Tau(273−284)-NH2, and z is the
net charge of the complex. Cross-sections for the mixed
aggregate peaks were determined by their ATDs. The
experimental cross-sections are accurate to 1%.44 Figure 3B
qualitatively represents the correlated cross-section of Ac-
Aβ(25−35)-NH2 monomer and oligomers extracted from the
experimental cross-section of the heteroligomers (see Support-
ing Information section S2.1 and Table S1),32 assuming that
the Tau conformation is relatively compact (as indicated from
simulation30). We note that σcorr (n) can be considered as
representative values for the ratios σexp(n,k)/σiso(n,k) between
the experimental cross-sections of heteroligomers and the
isotropic cross-section model of heteroligomers. Hence if
σexp(n,k) ≫ σiso(n,k), we expect a large deviation of σcorr(n)
from the isotropic cross-section of Aβ(25−35) oligomer,
σiso(n), indicating that the heteroligomers are nonisotropic.
Under this assumption, we observe that the cross-section
deviation occurs as early as heterodimers (n = 1, k = 1) and the
trend continues for larger oligomers (n = 3, k = 2 and n = 2, k =
3). The observation indicates that these heteroligomers adopt
extended conformations.56 This conclusion is generally true
regardless of our assumption that the Tau conformation is
compact. However, the largest heteroligomers observed in this
IM-MS experiment are hexamers, whereas, in the pure Ac-
Aβ(25−35)-NH2 sample, hexamers and nonamers can be
Figure 2. ESI−mass spectra of (A) Ac-Aβ(25−35)-NH2, (B) Ac-Tau(273−284)-NH2, and (C, D) a mixture of the two peptides at 1:1 ratio. The
concentration of each peptide is 200 μM in water. Each peak is annotated with [n + k]/z where n is the oligomer number of Ac-Aβ(25−35)-NH2, k
is the oligomer number of Ac-Tau(273−284)-NH2, and z is the net charge of the complex. A representative ATD of the peak at 705 m/z (k/z 1/2)
is shown in panel B to illustrate that dimer is the largest Tau oligomer formed under these conditions. Note that the dimer is relatively minor
compared to the monomer.
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unambiguously detected. Thus, it appears that Ac-Tau(273−
284)-NH2 can trap Ac-Aβ(25−35)-NH2 in smaller oligomeric
forms.
The significant intensities of the heterodimer peaks (i.e., [1 +
1]/4 at 627 m/z and [1 + 1]/3 at 837 m/z) indicate that the
Tau fragment has a high affinity to bind Ac-Aβ(25−35)-NH2
monomer relative to forming homo-Tau dimers (Kd in
micromolar range; see Supporting Information section S2.2).
T-REMD simulation57 of the heterodimer reveals the
existence of at least two major families of structures: compact
structures (∼40%, in which both Tau and Aβ peptide chains are
relatively compact) and extended structures (∼10%, where
both chains are extended in antiparallel configuration) and
other structures in between (see Supporting Information Figure
S3).
In terms of cross-sections, two populated clusters of
extended antiparallel heterodimers have average cross-sections
of σtheory = 553 and 525 Å
2 (clusters F and H shown in
Supporting Information Figure S3, respectively), which are in
good agreement with the [1 + 1]/4 species with the cross-
section of σexp = 559 Å
2. Similarly, the most populated compact
heterodimer clusters have average cross-sections of σtheory = 496
and 493 Å2 (clusters A and B, respectively), which agree well
with the [1 + 1]/3 species, σexp = 492 Å
2. We note that the
theoretical cross-section obtained from the trajectory method
available from the Mobcal package,54,55 from a specific
structure, is good to less than 5%.58,59
Figure 4A shows a schematic representation of the alignment
of two Tau(273−284) peptides, a mixed Tau(273−284)/
Aβ(25−35), and two Aβ(25−35) peptides within a single-layer
ideal β-sheet. In the context of a fragment such as Tau(273−
284) or full length Tau, the hydrophobic PHF6* region is
blocked between K274 at one end and K280/281 at the other
end, making associations between the hydrophobic PHF6*
cores more restricted. In the Ac-Tau(273−284)-NH2 extended
dimer conformation probed in the simulation of Larini et al.,30
the two PHF6* segments are shifted away from each other.
The extended dimer is stabilized by a weak hydrogen bonding
network between backbone atoms of hydrophobic residues
such as isoleucine and hydrophilic charged residues such as
lysine, consistent with the scheme shown in Figure 4A.
Since the two PHF6* segments are not within an optimal
distance to create a dry interface, the extended dimer structure
does not support steric zipper formation optimal for
fibrillization.46 On the other hand, the GAIIGL segment of
Figure 3. (A) Experimental cross-section of Ac-Aβ(25−35)-NH2 (σexp,
Å2) as a function of n. (B) Correlated cross-section of Ac-Aβ(25−35)-
NH2 + Ac-Tau(273-284)-NH2 (σcorr, Å
2) obtained from the
experimental cross-section of heteroligomers. The isotropic cross-
sections of Ac-Aβ(25−35)-NH2 are shown by the dashed line.
Figure 4. Proposed sequence alignments of the peptides in (A) single
extended β-sheet and (B) steric zipper conformation.
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Ac-Aβ(25−35)-NH2 can behave similarly to PHF6*, and the
adjacent residues around this segment are less charged than
those of Tau. In addition, since Ac-Aβ(25−35)-NH2 is one
residue shorter than Ac-Tau(273−284)-NH2 and the GAIIGL
segment is near the C-terminus, Figure 4A also proposes that a
better alignment between GAIIGL and PHF6* can be achieved
in antiparallel fashion.
Simulations suggest that both the homodimer of Tau(273−
284) and of Aβ(25−35) and the heterodimer of Tau(273−
284) and Aβ(25−35) can adopt antiparallel, extended
structures with the hydrogen bonding networks shown in
Figure 4A. The distributions of distances between hydrophobic
cores (between one PHF6* and another PHF6* in homo-
Tau(273−284) dimer, and between PHF6* and GAIIGL in the
heterodimer) suggest that the hydrophobic cores in the
heterodimer can interact more strongly (i.e., within a 5.0 Å
distance) than PHF6* in the homo-Tau(273−284) dimer (see
Supporting Information Figure S2 and Figure 5C).
According to Figure 4B, the interactions between two β-
sheets within a heterodimer steric zipper maintains interactions
at the dry interface similar to when PHF6* is considered alone,
with no charged residues in the dry interface. The homo-
Tau(273−284) steric zipper, on the other hand, is much less
stable, since it has to accommodate charged residues such as
lysine and aspartic acid within the dry interface and
hydrophobic residues such as isoleucine and leucine at the
wet interface. Therefore, it is reasonable to believe that
interactions between Ac-Aβ(25−35)-NH2 and Ac-Tau(273−
284)-NH2 can promote β-rich oligomers better than when Ac-
Tau(273−284)-NH2 is incubated separately.
As previously examined from both experiment and
theory,31,32 the aggregation process of Aβ(25−35) involves a
structural transition from dimer to trimer stages, in which a
compact dimer composed of mainly β-hairpin monomers
converts into extended β-rich structures, as shown in Figure 5B.
In these populated β-sheet oligomers (trimer or larger) the
hydrophobic cores are NKGAII whose locations are more
toward the middle of the chains, providing access to steric
zipper formation, and eventually fibril formation. NKGAII β-
sheets can interact in both face-to-face and back-to-back
fashions (Protein Data Bank (PDB) ID 3Q2X).42 Due to the
versatility of these interaction motifs, it is likely that these
NKGAII segments can provide a strong steric zipper interface
for Aβ(25−35) to quickly aggregate into fibrils.
The GAIIGL steric zipper (PDB ID 3PZZ) is composed of
antiparallel β-sheets interacting face-to-back. This class 6
zipper43 is often found in weakly aggregating systems such as
the islet amyloid polypeptide fragment NFLVHSS (PDB ID
3FTH),60 and the Enkephalin mutants YVVFV (4OLR) and
YVVFL (4ONK).61 Thus, we can predict that the heterosystem
of Aβ(25−35) and Tau(273−284) stabilized by PHF6*/
GAIIGL interactions would self-assemble with slower kinetics
into a different aggregate morphology as compared to pure
Aβ(25−35).
Heteroligomers Composed of Aβ(25-35) Monomer
and Oligomers but Not of Tau Oligomers Larger than
Dimer. In Figure 2C, two types of heteroligomers larger than
dimers are observed: (1) those with more Aβ than Tau peptide
chains, which will be referred to as hetero-Aβ oligomers and
(2) those with more Tau than Aβ, referred to as hetero-Tau
oligomers.
The hetero-Aβ oligomer peaks (i.e., [2 + 1]/4 at 903 m/z, [3
+ 2]/7 at 875 m/z, and [3 + 2]/6 at 1016 m/z) are abundant in
intensity indicating that Ac-Tau(273−284)-NH2 can effectively
replace Ac-Aβ(25−35)-NH2 peptide chains to form dimer,
trimer, and pentamer, and such processes are favorable. Similar
hetero-Tau oligomers are also observed (i.e., [1 + 2]/4 at 979
m/z and [2 + 3]/5 at 1280 m/z). At first glance, the
compositions of these hetero-Tau oligomers appear to be
similar to those of hetero-Aβ oligomers, which may suggest that
the Aβ and Tau peptides can randomly associate to form large
oligomers. However, as seen in Figure 6A,C, the ATDs of
Figure 5. Representative structures of the most populated extended
clusters obtained from the simulations of (A) blocked terminal homo-
Tau(273−284) dimers (see ref 30), (B) free terminal homo- Aβ(25−
35) trimers (see ref 31) and, (C) blocked terminal hetero-Tau(273−
284)/Aβ(25−35) dimers. The interacting hydrophobic cores are
highlighted using the same color codes shown in Figure 4. The
isoleucine pairs within the hydrophobic stretches are shown in licorice.
Figure 6. Representative ATDs of hetero-Aβ and hetero-Tau trimer
(A,B) and pentamer (C,D) peaks. Each feature is annotated with an
experimental cross-section (σ, Å2). Possible configurations of the
heteroligomers are shown with Ac-Aβ(25−35)-NH2 in red and Ac-
Tau(273−284)-NH2 in blue.
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hetero-Aβ oligomers (i.e., trimer and pentamer) present
multiple features and a variety of compact and extended
conformations with similar intensities. On the other hand, the
ATDs of hetero-Tau oligomers contain a dominant feature with
few minor features (Figure 6B,D). A possible explanation is that
since homoligomers of Ac-Tau(273−284)-NH2 larger than
dimers are not stable and populated in water, the number of
possible arrangements that hetero-Tau oligomers can adopt
should always be less than that of hetero-Aβ oligomers.
The hetero-Aβ trimer ATD has two peaks with cross-sections
of σexp = 673 and 706 Å
2 which mechanistically can be assigned
to a trimer composed of two Aβ monomers and a Tau
monomer intercalating in between (i.e., ABA) and a trimer of
an Aβ dimer and a Tau monomer (i.e., AAB configuration
where A is an Ac-Aβ(25−35)-NH2 and B is an Ac-Tau(273−
284)-NH2 monomer). It is worth noting that if both ABA and
AAB adopt similar conformations (i.e., extended structures)
then the cross-section σ(AAB) should be larger than that of
σ(ABA), since the former structure would have more Tau side
chains exposed to the outside (Tau is larger in size than Aβ),
which increases the collision cross-section. Both features are
populated since the Aβ monomer and dimer in the sample are
abundant (see Supporting Information Figure S1) . On the
other hand, the hetero-Tau trimer has three features, but the
shortest and longest arrival time features are very minor.
Statistically the BBA/ABB structures are more likely than the
BAB structures (i.e., the BBA/ABB can be formed starting with
either AB heterodimer or BB homodimer, whereas the BAB can
only be formed from the heterodimer) suggesting this is the
structure of the major peak, but this cannot be determined with
certainty.
Global stabilization of each quaternary structure often
involves not only strong pairwise interactions between adjacent
chains but also a network of noncovalent contacts among
different subunits. Consequently, the preceding mechanistic
description of heteroligomers appears to be too simple.
However, the T-REMD simulations of hetero-Aβ and hetero-
Tau trimers qualitatively support such a description. As seen in
Figure 7A, the radial distribution function (RDF g(r))
computed for the distances between the Aβ monomers within
the hetero-Aβ trimers populates several peaks near 0.5 and 1.0
nm. The distance of 0.5 nm indicates that the two Ac-Aβ(25−
35)-NH2 peptides are adjacent to each other (AAB
conformations), whereas that of 1.0 nm suggests the Tau
peptide is intercalating in between (ABA conformations).
Clustering analysis shows that the conformation of each chain
within a structure type can be either compact or extended,
which gives rise to a diverse set of conformations. The
representative structures and the theoretical cross-sections of
the major clusters obtained from the simulation of hetero-Aβ
trimer are shown in Supporting Information Figure S4. While
the Tau monomer is relatively extended, the two Ac-Aβ(25−
35)-NH2 chains can adopt either β-hairpin-like or extended
structures. Although the largest experimental cross-section of
the hetero-Aβ trimer is ∼10% larger than the reported
theoretical cross-sections, if we consider the broad distributions
of theoretical cross-sections, the theory and experiment are in
good agreement. Some oligomers may be kinetically but not
thermodynamically stable. Kinetically stable oligomers have
been observed and discussed in our recent study of free
terminal Aβ(25−35) aggregation.32
For the hetero-Tau trimer, all of the dominant peaks of g(r)
are located near 0.5 nm, suggesting that the BBA conformations
are dominant, in agreement with the assignment made in
Figure 6B. Clustering analysis of the hetero-Tau trimers
obtained from T-REMD reveals that a majority of extended
structures is of BBA type. Some compact, disordered structures
are also observed (see Supporting Information Figure S5).
As the size of the heteroligomers grows, a clear distinction
between hetero-Aβ and hetero-Tau oligomers is observed in
the IM-MS data. For the heteropentamer, those of Aβ contain
multiple features in the ATDs corresponding to different
species (i.e., there are six possible configurations of hetero-Aβ
pentamer). Since the size of the systems is expensive for high-
level MD simulations, we constructed a series of fully extended
hetero-Aβ pentamers corresponding to the configurations
shown schematically in Figure 6 (see Supporting Information
Figure S6 for the structures obtained from simulation and their
theoretical cross-sections). These antiparallel β-sheet models
have cross-sections in good agreement with the experiment
cross-sections for both charge states (z = +6 and +7),
suggesting the hetero-Aβ pentamers adopt extended, β-sheet-
like structures.
In contrast, the formation of the single hetero-Tau pentamer
is conformationally restricted, as manifested in the ATD
containing only one narrow feature. This feature has a smaller
cross-section and lower charge state than the hetero-Aβ
Figure 7. Radial distribution functions RDFs g(r) computed for the
distances r (nm) (A) between the Ac-Aβ(25−35)-NH2 monomers
within the hetero-Aβ trimer and (B) between the Ac-Tau(273−284)-
NH2 monomers within the hetero-Tau trimer.
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pentamers, suggesting that the conformation is relatively more
compact.
Ac-Tau(273−284)-NH2 Acting as an Inhibitor That
Drives Ac-Aβ(25−35)-NH2 Self-Assembly into Both
Granular and Heterofibrillar Aggregates. Both the IM-
MS data and the T-REMD simulations support extended
conformations of both Ac-Aβ(25−35)-NH2 and Ac-Tau(273−
284)-NH2 as early as the heterodimer stage. Figure 8 shows the
differences in quantities and morphologies of aggregates in the
pure Aβ(25−35), Tau(273−284), and mixture samples. From
these data, we conclude that the formation of heteroligomers
does not lead to enhanced fibril formation. The behavior of Ac-
Tau(273−284)-NH2 is similar to an inhibitor affecting the
aggregation process of Ac-Aβ(25−35)-NH2, in which Tau
monomer (and some dimer) competitively binds to Ac-
Aβ(25−35)-NH2 monomer and oligomers. For the sample of
pure Ac-Aβ(25−35)-NH2, abundant fibrillar aggregates are
observed (Figure 8A and Supporting Information Figure S7C−
F), whereas less fibrils but more granular aggregates are seen in
the mixture sample (Figure 8B) and finally no aggregates are
found in the pure Tau(273−284) sample (Figure 8C). This
raises two questions:
(1) What is the nature of the granular aggregates and fibril-
like structures observed in the AFM image of the mixture?
(2) Through which mechanisms does Ac-Tau(273−284)-
NH2 limit the strong aggregation of Ac-Aβ(25−35)-NH2 and
why do the extended conformations of heteroligomers,
observed by experiment and by theoretical modeling, not
promote abundant formation of fibrils?
To answer the first question, we consider the following
possibilities. The granular aggregates can be either (a) homo-
Tau aggregates, (b) early globular aggregates of homo-Aβ(25−
35), or (c) a type of new aggregate produced by the
heteroligomers. Granular aggregates have been observed as
intermediates in some Tau fragment aggregation62 but not
specifically for Ac-Tau(273−284)-NH2 in the absence of
aggregation-promoting factor (see Figure 8C). In the presence
of 11 kDa polydisperse heparin at 4:1 peptide:heparin ratio,
aggregation of Ac-Tau(273−284)-NH2 in water occurs within 1
h to form abundant well-defined aggregates (see Supporting
Information Figure S7A,B) and no granular aggregates are
detected. Thus, the granular aggregates observed in the mixture
sample should not be from the Tau itself; this eliminates option
a of homo-Tau oligomers.
We now consider option b: homo-Aβ oligomers. We note
that, in our experiment, fresh Ac-Aβ(25−35)-NH2 forms large,
β-rich oligomers within a short time after sample preparation
and forms fibrillar aggregates within an hour (Supporting
Information Figure S7C,D), suggesting that there is not a
noticeable morphology transition occurring during the
aggregation of Ac-Aβ(25−35)-NH2. A few small aggregates
are sparsely distributed at the edges of the AFM slide
(Supporting Information Figure S7G,H). However, these
aggregates vary widely in length and have on average a lower
height than the granular aggregates observed in the mixture
sample which suggests a different composition (see Table 1).
We consider the possibility that Ac-Tau(273−284)-NH2 acts as
an inhibitor to efficiently disassemble Ac-Aβ(25−35)-NH2
fibrils into globular aggregates. In other words, the interactions
between Ac-Tau(273−284)-NH2 and Ac-Aβ(25−35)-NH2
must be significantly stronger than Aβ(25−35) with itself in
order to successfully compete with existing interactions
between Aβ chains inside the fibrils. To examine whether Ac-
Tau(273−284)-NH2 can disaggregate Ac-Aβ(25−35)-NH2
fibrils, fresh Tau was added to a week-old sample containing
extensive fibrillar aggregates of Ac-Aβ(25−35)-NH2. No
Figure 8. Representative AFM images of (A, B) 1 week incubated 200
μM Ac-Aβ(25−35)-NH2 in water without Ac-Tau(273−284)-NH2
and with Ac-Tau(273−284)-NH2 at the ratio of 1:1 and (C) 2 week
incubated 200 μM Ac-Tau(273−284)-NH2 in water.
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decrease in fibrillar aggregate abundance was observed. From
the data, it is clear that Ac-Tau(273−284)-NH2 does not
disassemble Ac-Aβ(25−35)-NH2 aggregates, which eliminates
b as an option (see Supporting Information Figure S8).
Finally, we turn to option c, the possibility of forming mixed
aggregates. As seen in IM-MS and in simulations, Ac-Tau(273−
284)-NH2 and Ac-Aβ(25−35)-NH2 can interact. It is hence
reasonable to assume that Ac-Tau(273−284)-NH2 can
decorate existing Ac-Aβ(25−35)-NH2 oligomers and proto-
fibrils by occasionally adding on the growing aggregate in place
of new Aβ chains. The more Aβ that are replaced by Tau, the
less prone the oligomers are to grow further since there are
structural differences between hetero-Aβ and hetero-Tau
oligomers. Therefore, option c is the most probable. Compact
hetero-Tau and some hetero-Aβ oligomers can trap Ac-Aβ(25−
35)-NH2 oligomers in β-hairpin or β-turn conformations,
leading to the formation of granular aggregates. Since Ac-
Tau(273−284)-NH2 monomer is larger than Ac-Aβ(25−35)-
NH2 monomer in size, the fibrils grown from heteroligomers
would be more likely to have larger dimensions than the pure
Ac-Aβ(25−35)-NH2 fibrils. Additional AFM measurements
show that both heights and lengths of the fibrils and granular
features formed in the mixture sample are greater than those of
the pure Ac-Aβ(25−35)-NH2 (see Table 1). In these
measurements, only the dimension of individual fibrils is
taken into account, and the larger features which are probably
clusters of several fibrils are not considered.
For the second question, we first consider the mechanisms
through which Aβ(25−35) can aggregate. The simulations of
Ac-Aβ(25−35)-NH2 by Wei et al.28 show the existence of a V-
shaped parallel dimer, an out of register antiparallel dimer, and
an intertwined β-hairpin conformation at small populations as
potential seeds for amyloid formation. The major driving force
for the first two families of structures is hydrophobic
interactions between GAIIGL segments. Larini and Shea,31 in
simulations of Aβ(25−35), suggest that the transition from β-
hairpin Aβ(25−35) monomer to extended structures of
oligomers is regulated by a competition between electrostatics
and hydrophobic effects. Electrostatics dominate for dimer
formation to produce mainly compact structures composed of
two tilted β-hairpin monomers, whereas hydrophobic inter-
actions facilitate the β-sheet trimers and tetramers. They also
propose the role of β-hairpin structure in a kinetic growth
model as a means to stabilize flat β-sheets and prevent newly
formed oligomers from hydrophobic collapse. When Ac-
Tau(273−284)-NH2 and Ac-Aβ(25−35)-NH2 form extended
dimers, or Ac-Tau(273−284)-NH2 intercalates between Ac-
Aβ(25−35)-NH2 hairpins at the trimer or pentamer, Tau limits
the influences of β-hairpin structure in the growth of Aβ(25−
35) fibrils and subsequently decreases the aggregation
propensity. By replacing the hydrophobic core of NKGAII/
NKGAII with PHF6*/GAIIGL, and limiting the role of
Aβ(25−35) hairpins, Ac-Tau(273−284)-NH2 decreases the
aggregation propensity of Ac-Aβ(25−35)-NH2. The hetero-Aβ
oligomers are relatively extended, but not as aggregation-prone
as the homo-Aβ oligomers, due to the mismatches in side-chain
interdigitations and their heterogeneity. The presence of a few
Tau chains within the heterocomplexes may decrease the ability
to self-associate, but the system is still able to grow further into
fibrils, which is consistent with what has been observed in the
AFM image of the mixture (Figure 8B).
It has been long predicted that heterotypic β-sheet and steric
zipper structures can exist. Eisenberg and co-workers have
shown that the macroscopic morphologies and abundances of
fibrillar aggregates formed in binary mixtures of different Aβ
segments are distinct from the component segments.42
However, no X-ray crystal structures of heterotypic β-sheet
and steric zipper have been solved. One of the possible
explanations is that even in a binary system of two short
peptides, the tendency of homotypic structure formation is
dominant, and crystallization is highly dependent upon the
kinetics and growth conditions which are very selective. The
two factors often promote the crystallization of one type or the
other, but not heterotypic crystals. Thus, IM-MS appears to be
a versatile technique to approach this problem. Previous work
has shown that the experimental cross-sections of aggregating
peptide oligomers are in good agreement with X-ray crystal
structures.56 Furthermore, even a small amount of hetero-
ligomers can be detected with this technique.
■ SUMMARY AND CONCLUSIONS
(1) Using a combination of experimental and theoretical
techniques, we are able to identify the interactions promoting
and stabilizing Ac-Aβ(25−35)-NH2/Ac-Tau(273−284)-NH2
heteroligomers. The formation of heteroligomers triggers
conformation transitions from compact to extended forms for
both peptides as early as the dimer stage. Ac-Tau(273−284)-
NH2 monomer prefers to associate with an Ac-Aβ(25−35)-
NH2 monomer over another Tau monomer as shown by the
populations of heterodimer and homo-Tau dimer in the
mixture. The intercalation of Ac-Tau(273−284)-NH2 mono-
mers between Ac-Aβ(25−35)-NH2 monomers (and oligomers)
is a probable mechanism allowing large heteroligomers to grow
with a wide range of configurations and conformations.
(2) The heterogeneity of the heteroligomers and mismatches
in side-chain interdigitations limit (but do not fully eliminate)
aggregation. The hetero-Tau oligomers can be trapped at
relatively small sizes, producing granular aggregates. On the
other hand, the architectures of hetero-Aβ oligomers contain β-
rich content, which later can grow into heterofibrils, as
illustrated in Figure 9.
(3) A possible source of toxicity of early Aβ oligomers may
lie in their ability to bind Tau monomers, thereby decreasing
the population of Tau needed to regulate microtubule
dynamics. Other possible pathways to toxicity lie in the
structures of the heteroligomers formed by the interactions of
different Tau to Aβ fragments, which awaits a further systematic
investigation.
(4) IM-MS can probe conformations and abundances of
heteroligomers, demonstrating its capacity as a promising
screening method to identify important segments from different
aggregating proteins (e.g., Aβ, Tau, prion, islet amyloid
polypeptide) that can interact with each other to form
heterotypic structures. These studies will provide insights into
Table 1. Dimension (Height (nm) and Length (nm)) of the
Aggregates Observed by AFM for the Samples of Pure Ac-
Aβ(25-35)-NH2 and 1:1 Mixture of Ac-Aβ(25-35)-NH2 and
Ac-Tau(273-284)-NH2 at 200 μM
type of aggregate figure height (nm) length (nm)
Aβ(25−35) fibrils 8A 4.18 ± 0.36 332.7 ± 29.9
Aβ(25−35) small aggregates S7H,Ia 5.16 ± 0.61 n/a
mixed fibrils 8B 5.20 ± 0.26 443.8 ± 22.4
granular aggregates 8B 6.50 ± 0.51 81.7 ± 5.4
aSupporting Information.
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synergy effects of protein markers responsible for aggregation-
related diseases, which are currently challenging to unravel.
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